Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Amphotericin A |
Is a |
True |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin B (substance) |
Is a |
True |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin adverse reaction |
Causative agent (attribute) |
True |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin allergy |
Causative agent (attribute) |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin [anti fungal] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin 50mg/10mL intravenous infusion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
amphotéricine 5 mg/mL, flacon de 20 mL de concentré pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
amphotéricine 100 mg, fiole de poudre pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin 100mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin 100mg/mL s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin 50mg i-v infusion (pdr for recon) (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin [gynecological use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin [oropharyngeal] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amphotericin B 10 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin (lipid formulation) 50mg powder for infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amphotericin in oral dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing amphotericin in parenteral dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin b 50mg infusion solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amphotericin in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin measurement (procedure) |
Component |
True |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing amphotericin and tetracycline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin allergy |
Causative agent (attribute) |
True |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nephropathy caused by amphotericin (disorder) |
Causative agent (attribute) |
True |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin 100mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin 100mg tablet (substance) |
Has basis of strength substance (attribute) |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin B cholesteryl sulfate complex |
Is a |
True |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin B lipid complex |
Is a |
True |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin B liposome (substance) |
Is a |
True |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin 5mg/mL conventional release suspension for injection 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin 100mg tablet (substance) |
Has precise active ingredient |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amphotericin B phospholipid complex (substance) |
Is a |
True |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amphotericin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only amphotericin and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only amphotericin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only amphotericin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only amphotericin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only amphotericin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amphotericin |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |